What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in ...

Inspire Medical Systems’ first quarter showed strong momentum, as results exceeded Wall Street’s expectations for both ...

Inspire Medical Systems, Inc. announced preliminary fourth quarter and full year 2024 financial results, revealing anticipated revenues of approximately $239.5 million to $239.7 million for Q4, ...

Inspire Medical Systems, Inc. (INSP) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...

Inspire Medical Systems, Inc. announced strong financial performance for the fourth quarter and full year of 2024, reporting a 25% increase in revenue for Q4, totaling $239.7 million, and a 28% ...

Inspire Reports First Profitable Quarter and Year-over-Year Revenue Growth of 76% in the Fourth QuarterMINNEAPOLIS, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Inspire Medical Systems (INSP – Research Report), with a price target of $187.00. Larry Biegelsen has ...

Inspire Medical Systems (INSP 2.09%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10.

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13. Discover outperforming stocks and invest smarter with Top Smart Score ...

If a traditional CPAP machine isn't for you, you might consider the Inspire sleep apnea device as an alternative treatment option. Here's what you need to know.